{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:33:59Z","timestamp":1769315639554,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12020-019-02095-5","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T08:02:51Z","timestamp":1569657771000},"page":"243-251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-6278","authenticated-orcid":false,"given":"Maximilien","family":"Minon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clothilde","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Morland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Deblock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralie","family":"Barbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hoeffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Cadiot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,28]]},"reference":[{"issue":"10","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"A. Dasari, C. Shen, D. Halperin, B. Zhao, S. Zhou, Y. Xu et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3(10), 1335\u20131342 (2017)","journal-title":"JAMA Oncol."},{"issue":"1","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"I.M. Modlin, K. Oberg, D.C. Chung, R.T. Jensen, W.W. de Herder, R.V. Thakker et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 9(1), 61\u201372 (2008)","journal-title":"Lancet Oncol."},{"issue":"2","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000182196","volume":"90","author":"G Kl\u00f6ppel","year":"2009","unstructured":"G. Kl\u00f6ppel, A. Couvelard, A. Perren, P. Komminoth, A.M. McNicol, O. Nilsson et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90(2), 162\u2013166 (2009)","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000225952","volume":"90","author":"R Arnold","year":"2009","unstructured":"R. Arnold, Y.-J. Chen, F. Costa, M. Falconi, D. Gross, A.B. Grossman et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: follow-up and documentation. Neuroendocrinology 90(2), 227\u2013233 (2009)","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2095_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/MPA.0b013e3181ebaffd","volume":"39","author":"AI Vinik","year":"2010","unstructured":"A.I. Vinik, E.A. Woltering, R.R. Warner, M. Caplin, T.M. O\u2019Dorisio, G.A. Wiseman et al. NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39(6), 713\u2013734 (2010)","journal-title":"Pancreas"},{"key":"2095_CR6","unstructured":"G. Cadiot, E. Baudin, R. Coriat et al. Tumeurs neuroendocrines digestives. The\u0301saurus National de Cance\u0301rologie Digestive, SNFGE (Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de Gastro-ent\u00e9rologie). Chapter 11. \nhttps:\/\/www.snfge.org\/sites\/default\/files\/SNFGE\/TNCD\/tncd_chap-11-tned_2017-10-12.pdf"},{"issue":"3","key":"2095_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"A. Sundin, R. Arnold, E. Baudin, J.B. Cwikla, B. Eriksson, S. Fanti et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology 105(3), 212\u2013244 (2017)","journal-title":"Neuroendocrinology"},{"issue":"1","key":"2095_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2967\/jnumed.117.202275","volume":"59","author":"TA Hope","year":"2018","unstructured":"T.A. Hope, E.K. Bergsland, M.F. Bozkurt, M. Graham, A.P. Heaney, K. Hermann et al. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J. Nucl. Med. 59(1), 66\u201374 (2018)","journal-title":"J. Nucl. Med."},{"issue":"6","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","volume":"16","author":"MH Shah","year":"2018","unstructured":"M.H. Shah, W.S. Goldner, T.R. Halfdanarson, E. Bergsland, J.D. Berlin, D. Halperin et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018. J. Natl. Compr. Cancer Netw. 16(6), 693\u2013702 (2018)","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"2","key":"2095_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G D\u2019Assignies","year":"2013","unstructured":"G. D\u2019Assignies, P. Fina, O. Bruno, M.P. Vullierme, F. Turbach, V. Paradis et al. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology 268(2), 390\u2013399 (2013)","journal-title":"Radiology"},{"issue":"3","key":"2095_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000446369","volume":"104","author":"F Moryoussef","year":"2017","unstructured":"F. Moryoussef, L. de Mestier, M. Belkebir, S. Deguelte-Lardi\u00e8re, H. Brixi, R. Kianmanesh et al. Impact of liver and whole-body diffusion-weighted MRI for neuroendocrine tumors on patient management: a pilot study. Neuroendocrinology 104(3), 264\u2013272 (2017)","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"G. Rindi, G. Kl\u00f6ppel, H. Alhman, M. Caplin, A. Couvelard, W.W. de Herder et al. European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 449(4), 395\u2013401 (2006)","journal-title":"Virchows Arch."},{"key":"2095_CR13","unstructured":"R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai. WHO classification of tumours of endocrine organs. (International Agency for Research on Cancer, Lyon, France, 2017). pp. 211\u2013214"},{"issue":"12","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.diii.2016.07.012","volume":"97","author":"C Dromain","year":"2016","unstructured":"C. Dromain, D. D\u00e9andr\u00e9is, J.Y. Scoazec, D. Goere, M. Ducreux, E. Baudin et al. Imaging of neuroendocrine tumors of the pancreas. Diagn. Interv. Imaging 97(12), 1241\u20131257 (2016)","journal-title":"Diagn. Interv. Imaging"},{"issue":"1","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.2005.01.013","volume":"23","author":"C Dromain","year":"2005","unstructured":"C. Dromain, T. de Baere, J. Lumbroso, H. Caillet, A. Laplanche, V. Boige et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J. Clin. Oncol. 23(1), 70\u201378 (2005)","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"2095_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/RLI.0b013e3181afbb36","volume":"44","author":"TC Kwee","year":"2009","unstructured":"T.C. Kwee, H.M.E.Q. van Ufford, F.J. Beek, T. Takahara, C.S. Uiterwaal, M.B. Bierings et al. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Investig Radiol. 44(10), 683\u2013690 (2009)","journal-title":"Investig Radiol."},{"issue":"8","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s00330-010-1758-y","volume":"20","author":"C Lin","year":"2010","unstructured":"C. Lin, A. Luciani, E. Itti, T. El-Gnaoui, A. Vignaud, P. Beaussart et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur. Radiol. 20(8), 2027\u20132038 (2010)","journal-title":"Eur. Radiol."},{"issue":"3","key":"2095_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejrad.2009.04.059","volume":"75","author":"V Laurent","year":"2010","unstructured":"V. Laurent, G. Trausch, O. Bruot, P. Olivier, J. Felblinger, D. R\u00e9gent, Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur. J. Radiol. 75(3), 376\u2013383 (2010)","journal-title":"Eur. J. Radiol."},{"issue":"10","key":"2095_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2967\/jnumed.114.144543","volume":"55","author":"ECS Etchebehere","year":"2014","unstructured":"E.C.S. Etchebehere, C. de, A. de Oliveira Santos, B. Gumz, A. Vicente, P.G. Hoff, G. Corradi et al. 68Ga-DOTATATE PET\/CT, 99mTc-HYNIC-octreotide SPECT\/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial. J. Nucl. Med. 55(10), 1598\u20131604 (2014)","journal-title":"J. Nucl. Med."},{"key":"2095_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1102\/1470-7330.2013.0007","volume":"13","author":"C Schraml","year":"2013","unstructured":"C. Schraml, N.F. Schwenzer, O. Sperling, P. Aschoff, M.P. Lichy, M. M\u00fcller et al. Staging of neuroendocrine tumours: comparison of 68GaDOTATOC multiphase PET\/CT and whole-body MRI. Cancer Imaging 13, 63\u201372 (2013)","journal-title":"Cancer Imaging"},{"issue":"1","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/03009734.2016.1248803","volume":"122","author":"L Carlbom","year":"2017","unstructured":"L. Carlbom, J. Caballero-Corbalan, D. Granberg, J. S\u00f6rensen, B. Eriksson, H. Ahlstr\u00f6m, Whole-body MRI including diffusion-weighted MRI compared with 5-HTP PET\/CT in the detection of neuroendocrine tumors. Upsala J. Med. Sci. 122(1), 43\u201350 (2017)","journal-title":"Upsala J. Med. Sci."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-02095-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-02095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T23:45:13Z","timestamp":1601163913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-02095-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,28]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-02095-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,28]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}